vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $32.0M, roughly 1.6× Silvercrest Asset Management Group Inc.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -71.6%, a 71.2% gap on every dollar of revenue. On growth, Silvercrest Asset Management Group Inc. posted the faster year-over-year revenue change (-0.0% vs -11.8%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-24.9M). Over the past eight quarters, Silvercrest Asset Management Group Inc.'s revenue compounded faster (2.7% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

MRVI vs SAMG — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.6× larger
MRVI
$49.9M
$32.0M
SAMG
Growing faster (revenue YoY)
SAMG
SAMG
+11.8% gap
SAMG
-0.0%
-11.8%
MRVI
Higher net margin
SAMG
SAMG
71.2% more per $
SAMG
-0.4%
-71.6%
MRVI
More free cash flow
SAMG
SAMG
$39.9M more FCF
SAMG
$15.0M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
SAMG
SAMG
Annualised
SAMG
2.7%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
SAMG
SAMG
Revenue
$49.9M
$32.0M
Net Profit
$-35.7M
$-120.0K
Gross Margin
25.8%
Operating Margin
-117.9%
-2.8%
Net Margin
-71.6%
-0.4%
Revenue YoY
-11.8%
-0.0%
Net Profit YoY
-37.7%
-107.4%
EPS (diluted)
$-0.24
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
SAMG
SAMG
Q4 25
$49.9M
$32.0M
Q3 25
$41.6M
$31.3M
Q2 25
$47.4M
$30.7M
Q1 25
$46.9M
$31.4M
Q4 24
$56.6M
$32.0M
Q3 24
$69.0M
$30.4M
Q2 24
$69.4M
$31.0M
Q1 24
$64.2M
$30.3M
Net Profit
MRVI
MRVI
SAMG
SAMG
Q4 25
$-35.7M
$-120.0K
Q3 25
$-25.6M
$618.0K
Q2 25
$-39.6M
$1.9M
Q1 25
$-29.9M
$2.5M
Q4 24
$-25.9M
$1.6M
Q3 24
$-97.1M
$2.3M
Q2 24
$-9.8M
$2.7M
Q1 24
$-12.1M
$3.0M
Gross Margin
MRVI
MRVI
SAMG
SAMG
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
MRVI
MRVI
SAMG
SAMG
Q4 25
-117.9%
-2.8%
Q3 25
-98.6%
4.3%
Q2 25
-139.8%
13.2%
Q1 25
-104.9%
15.4%
Q4 24
-66.7%
6.1%
Q3 24
-239.9%
14.6%
Q2 24
-19.4%
17.1%
Q1 24
-29.4%
19.5%
Net Margin
MRVI
MRVI
SAMG
SAMG
Q4 25
-71.6%
-0.4%
Q3 25
-61.4%
2.0%
Q2 25
-83.5%
6.3%
Q1 25
-63.9%
7.9%
Q4 24
-45.8%
5.1%
Q3 24
-140.6%
7.4%
Q2 24
-14.1%
8.6%
Q1 24
-18.8%
9.9%
EPS (diluted)
MRVI
MRVI
SAMG
SAMG
Q4 25
$-0.24
$0.02
Q3 25
$-0.18
$0.07
Q2 25
$-0.27
$0.21
Q1 25
$-0.21
$0.26
Q4 24
$-0.21
$0.16
Q3 24
$-0.68
$0.24
Q2 24
$-0.07
$0.28
Q1 24
$-0.09
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
SAMG
SAMG
Cash + ST InvestmentsLiquidity on hand
$216.9M
$44.1M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$212.4M
$50.3M
Total Assets
$770.6M
$166.6M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
SAMG
SAMG
Q4 25
$216.9M
$44.1M
Q3 25
$243.6M
$36.1M
Q2 25
$269.9M
$30.0M
Q1 25
$285.1M
$36.3M
Q4 24
$322.4M
$68.6M
Q3 24
$578.2M
$58.1M
Q2 24
$573.2M
$49.9M
Q1 24
$561.7M
$39.7M
Total Debt
MRVI
MRVI
SAMG
SAMG
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
MRVI
MRVI
SAMG
SAMG
Q4 25
$212.4M
$50.3M
Q3 25
$245.4M
$58.9M
Q2 25
$265.9M
$64.6M
Q1 25
$300.6M
$80.0M
Q4 24
$325.3M
$80.7M
Q3 24
$344.9M
$84.6M
Q2 24
$434.7M
$85.3M
Q1 24
$410.7M
$83.9M
Total Assets
MRVI
MRVI
SAMG
SAMG
Q4 25
$770.6M
$166.6M
Q3 25
$849.2M
$157.6M
Q2 25
$897.0M
$152.7M
Q1 25
$959.8M
$159.9M
Q4 24
$1.0B
$194.4M
Q3 24
$1.3B
$184.2M
Q2 24
$1.4B
$177.6M
Q1 24
$1.4B
$170.2M
Debt / Equity
MRVI
MRVI
SAMG
SAMG
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
SAMG
SAMG
Operating Cash FlowLast quarter
$-22.8M
$18.6M
Free Cash FlowOCF − Capex
$-24.9M
$15.0M
FCF MarginFCF / Revenue
-49.9%
46.9%
Capex IntensityCapex / Revenue
4.2%
11.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M
$17.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
SAMG
SAMG
Q4 25
$-22.8M
$18.6M
Q3 25
$-15.2M
$14.6M
Q2 25
$-10.3M
$13.8M
Q1 25
$-9.4M
$-24.7M
Q4 24
$-14.6M
$21.6M
Q3 24
$13.1M
$13.3M
Q2 24
$17.4M
$16.0M
Q1 24
$-8.5M
$-24.1M
Free Cash Flow
MRVI
MRVI
SAMG
SAMG
Q4 25
$-24.9M
$15.0M
Q3 25
$-18.1M
$13.8M
Q2 25
$-13.1M
$13.4M
Q1 25
$-14.6M
$-25.1M
Q4 24
$-20.5M
$19.9M
Q3 24
$4.5M
$12.9M
Q2 24
$7.9M
$15.6M
Q1 24
$-14.1M
$-24.7M
FCF Margin
MRVI
MRVI
SAMG
SAMG
Q4 25
-49.9%
46.9%
Q3 25
-43.4%
44.1%
Q2 25
-27.7%
43.6%
Q1 25
-31.2%
-80.0%
Q4 24
-36.2%
62.2%
Q3 24
6.6%
42.4%
Q2 24
11.4%
50.4%
Q1 24
-22.0%
-81.6%
Capex Intensity
MRVI
MRVI
SAMG
SAMG
Q4 25
4.2%
11.4%
Q3 25
7.0%
2.6%
Q2 25
6.1%
1.5%
Q1 25
11.2%
1.3%
Q4 24
10.3%
5.3%
Q3 24
12.4%
1.2%
Q2 24
13.8%
1.1%
Q1 24
8.8%
2.0%
Cash Conversion
MRVI
MRVI
SAMG
SAMG
Q4 25
Q3 25
23.62×
Q2 25
7.22×
Q1 25
-10.01×
Q4 24
13.34×
Q3 24
5.90×
Q2 24
6.00×
Q1 24
-8.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

SAMG
SAMG

Investment Advisory Management And Administrative Service$30.7M96%
Tax And Family Office Services$1.2M4%

Related Comparisons